📢📢📢

Epidemiology 101 Course for Journalists via @mcgillu @McGill_SPGH @McGillEBOH

Featuring guest lectures from @rkhamsi @VidyaKrishnan @apoorva_nyc @marynmck & @picardonhealth

May 3 - 7, 2021, fully online

Register at mcgill.ca/epi-biostat-oc…
Rationale for this course is summarized in my blog:

Journalists Need To Get It Right: Epidemiology Training Can Help

forbes.com/sites/madhukar…
For journalists who are not able to pay & register, my previous course slides & videos are online & free to access!

teachepi.org/courses/epidem…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Madhu Pai, MD, PhD

Madhu Pai, MD, PhD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @paimadhu

12 Feb
On "clinical deserts" in global health:

Folks in global health often care about vaccinations, bed-nets, WASH & other public health measures.

This is important, but what communities first want is medical treatment for people who are sick.

Good projects address BOTH needs!
As Paul Farmer & other clinicians in global health point out:

"People, when they are sick, are not looking to be sprayed, controlled, counselled, told about bush meat... they are looking to survive, and when they see the quality of care is not good, they are going to flee"
Farmer uses Ebola in West Africa to illustrate how dominant this "control-over-care" paradigm is in the global health, and why it has its origins in colonial medicine. See my interview:

forbes.com/sites/madhukar…
Read 13 tweets
3 Jan
History lesson:

When anti-retrovirals were developed for HIV in the 90s, drug-makers had no interest in Africa ("not a lucrative market") & ART was unaffordable.

Zidovudine was marketed at a price of US$8000 per year!
We are seeing the same lack of pharma interest in providing affordable #COVID19 vaccines for Africa

bloomberg.com/news/articles/…
After a lot of global advocacy, widespread access to affordable ARVs became feasible after Cipla, a generics Indian manufacturer offered triple therapy for less than a dollar a day.

Full story here: …balizationandhealth.biomedcentral.com/articles/10.11…
Read 8 tweets
2 Dec 20
Just finished teaching my online global health course!

Some reflections & lessons
Because it was online, I invited speakers from around the world - a HUGE change from the past and the single most impactful change.

75% of course faculty were Black, Indigenous or POC

LMIC faculty lit up the course with their authenticity, credibility & lived experience!
Other changes that worked well:

- Began with colonialism lectures
- Sessions on privilege, anti-oppression, anti-racism and allyship
- Content on power asymmetry in global health & decolonizing GH
Read 10 tweets
13 Oct 20
In my global health course today, we will cover pandemics.

My summary of the major lessons from #COVID19 (so far):

1. Something like #COVID19 was expected, but countries were not prepared (despite all the post-Ebola commissions)

2. Global governance is fragmented and failing
3. WHO's response is under review & findings must be used to strengthen the agency

4. US is no longer a credible leader in global health

5. Nationalism & isolationism have become amplified during the pandemic
6. Countries suppress information & underplay the scale of the problem - not easy to hold them accountable

7. Science is under attack & infodemics are hard to fight

8. Political interference has greatly weakened public health agencies & experts

9. Bad leadership costs lives
Read 6 tweets
13 Sep 20
Thread on racism in #tuberculosis & global health.

I have been writing about power imbalance in global health.

Every aspect of global health is dominated by individuals, institutions and funders in HICs. Global health is neither global nor diverse.

forbes.com/sites/madhukar…
This NYT piece by @apoorva_nyc brought this discussion home to my own field of tuberculosis. It hits me hard because I know the people, and I served on the Board of @StopTB. I care about the agency & have given my time/expertise.

nytimes.com/2020/09/12/hea…
I respect the Board's independent investigation and look forward to the findings.

Whatever the outcome, it is critical to use this moment to reflect on the structural issues that make tuberculosis problematic. Otherwise, nothing will change.
Read 34 tweets
6 Aug 20
Thread on 'global health degrees:

Ever wondered what a "Master's degree in Global Health" might cost you?

In our @GlobalHealthBMJ paper, by @svadzianita @av_Nathaly & @seyeabimbola, we identified 41 degree programs & estimated total tuition costs.

gh.bmj.com/content/bmjgh/…
Vast majority of such degree programs are in Europe & North America.

Across all 41 degree programs, the mean tuition fee was US $41,790 for international students and US $33,603 for domestic students.

This does NOT include living expenses, travel, healthcare or other costs.
Tuition was higher for international students, on-campus degrees, and in private schools. Even online degrees cost US $19353.

For US schools, the average tuition fee for all students was US $68,093. There was little difference between domestic and international student fees.
Read 18 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!